Wednesday, April 16, 2025
Home Internet News BDC

BDC

    Featured posts

    Owl Rock Capital Corp. II Files for Best-Efforts IPO (S&P Global)

    BDC Editor / Curator -
    Owl Rock Capital Corp II has filed a Form N-2 for an initial public offering of up to 150 million of its...
    David Lessen

    Interview with Former UBS Managing Director and Now COO of StHealth Capital David Lessen.

    BDC Editor / Curator -
    While not widely known, Wall Street’s Institutional Investment Managers and Registered Investment Advisors (RIA’s) love using BDC Investment Funds for their clients – to the...

    StHealth Capital, Our #1 Ranked Emerging BDC Idea.

    BDC Editor / Curator -
    Newly Launched Medtech & Biotech BDC Seeking Pre-IPO Stage Investments. This is easily one of the most exciting...
    video

    StHealth Private Equity Medtech Fund. Alternative Investment BDC.

    Video Editor / Curator -
    StHealth Capital (STHC, no symbol yet) has put together an amazing team to manage the Fund recently organized to provide investors with...

    Former Tesla Foundation Vice Chairman Joins StHealth BDC.

    BDC Editor / Curator -
    St Health Capital Investment Corporation is delighted to announce Dr. Robert GW Brown FAPS, FIEE, FInstP, MAE as a key new member to our board...

    Latest article

    GeoVax (GOVX) Down on JFK’s Continued Scale Backs to the Vaccine Sector.

    2025 Watch List Editor / Curator -
    Down 20% in response to news in an 8K that the Biomedical Advanced Research and Development Authority BARDA (also once known as the...

    Adding Allarity (ALLR) $0.70, to Watch List.

    2025 Watch List Editor / Curator -
    LIVE QUOTE SHORT TERM CHART Bargain Hunting? Adding to the...

    Bavarian Nordic (BVNRY) Freeze Dries its MPOX Vaccine!

    2025 Watch List Editor / Curator -
    This is Big News, Honestly. We Are Adding to 2025 Watch List @ $7.36. We last added Bavarian to...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.